Drugs Information: Obinutuzumab
Basic Information
|
|
||
| ID | DDInter1320 | |
| Drug Type | biotech | |
| Molecular Formula | C6512H10060N1712O2020S44 | |
| Molecular Weight | - | |
| Description | Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. | |
| ATC Classification | L01XC15 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Obinutuzumab
| Severity level | ID | Name | Mechanism | Detail |
|---|